Company Search:
Advanced Search
Sponsored Links
Genematrix Inc. Company Snapshot
Genematrix Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genematrix Inc. with three other companies in this sector in South Korea: Cancer Rop Co Ltd (2017 sales of 4.67 billion Korean Won [US$4.11 million] ), SillaJen Inc (6.86 billion Korean Won [US$6.05 million] ), and ATGen (4.83 billion Korean Won [US$4.25 million] of which 100% was Reagent & Cancer Diagnostic Kits).

Sales Analysis. Genematrix Inc. reported sales of 5.19 billion Korean Won (US$4.57 million) for the year ending December of 2017. This represents an increase of 2.2% versus 2016, when the company's sales were 5.08 billion Korean Won. Despite this increase, sales are still below the level achieved in 2015, when Genematrix Inc. reported sales of 5.32 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genematrix Inc.
  Stock Performance Chart for Genematrix Inc.
  Stock Data: Recent Stock Performance:
  Current Price (4/12/2019): 4,100.00
(Figures in Korean Won)
1 Week 2.8%   13 Weeks 5.7%  
4 Weeks 1.7%   52 Weeks -25.5%  
Genematrix Inc. Key Data:
  Ticker: 109820 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 5,189,162,538
(Year Ending Jan 2018).
Employees: 31
  Currency: Korean Won Market Cap: 62,822,438,600
  Fiscal Yr Ends: December Shares Outstanding: 15,322,546
  Share Type: Closely Held Shares: 5,123,507
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.